Skip to content

Functional Renal Hemodynamics in Patients with and without Renal Artery Stenosis 2

Functional Renal Hemodynamics in Patients with and without Renal Artery Stenosis 2 - HeRA 2 Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55815
Enrollment
28
Registered
2019-04-08
Start date
2019-07-30
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic renal artery stenosis renovasculair disease secundaire hypertensie

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age > 18 Written informed consent Clinically and hemodynamically stable Clinical indication for a coronary, renal, or peripheral vascular angiography with or without percutaneous intervention.

Exclusion criteria

Exclusion criteria: Recent ST-segment elevation myocardial infarction ( II) Increased risk for contrast nephropathy defined as presence of renal impairment (eGFR

Design outcomes

Primary

MeasureTime frame
Dynamic range of renal blood flow, represented by the relative baseline flow, the ratio between the difference of baseline and minimal flow velocity and baseline flow velocity.

Secondary

MeasureTime frame
Renal flow reserve, relative minimal flow, renal fractional flow reserve, baseline and hyperemic renal stenosis resistance, baseline and hyperemic microvascular resistance, phase difference between pressure and flow in sympathetic band for autoregulation. In patients where offline renal perfusion analysis is possible: renal perfusion as area under the curve of contrast density over time and the renal flow reserve computed by perfusion angiography. Correlation of main study parameters with relevant clinical, biochemical and imaging parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)